SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-124284
Filing Date
2023-04-28
Accepted
2023-04-28 10:39:03
Documents
23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d497936ddef14a.htm   iXBRL DEF 14A 1262868
6 GRAPHIC g497936g00a02.jpg GRAPHIC 70690
7 GRAPHIC g497936g00a03.jpg GRAPHIC 25532
8 GRAPHIC g497936g01c43.jpg GRAPHIC 97185
9 GRAPHIC g497936g01g00.jpg GRAPHIC 175559
10 GRAPHIC g497936g02g00.jpg GRAPHIC 167168
11 GRAPHIC g497936g06g70.jpg GRAPHIC 118348
12 GRAPHIC g497936g07m46.jpg GRAPHIC 114305
13 GRAPHIC g497936g69e71.jpg GRAPHIC 102930
14 GRAPHIC g497936g70f71.jpg GRAPHIC 102484
  Complete submission text file 0001193125-23-124284.txt   4544767

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA akba-20221231.xsd EX-101.SCH 7203
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20221231_def.xml EX-101.DEF 8065
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20221231_lab.xml EX-101.LAB 12984
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20221231_pre.xml EX-101.PRE 7707
17 EXTRACTED XBRL INSTANCE DOCUMENT d497936ddef14a_htm.xml XML 321406
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36352 | Film No.: 23861444
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences